Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival

International Journal of Cancer

Volumn 128, Issue 11, 2011, Pages 2726-2734

  Slattery, Martha L ^a   Curtin, Karen ^a   Poole, Elizabeth M ^b   Duggan, David J ^c   Samowitz, Wade S ^d   Peters, Ulrike ^b   Caan, Bette J ^e   Potter, John D ^b   Ulrich, Cornelia M ^b,f  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e DIVISION OF RESEARCH   (United States)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

BMI; C reactive protein; colon cancer; family history; genetic variation; inflammation; polymorphism; rectal cancer; survival

Indexed keywords

C REACTIVE PROTEIN;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CANCER RISK; CANCER SURVIVAL; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; CRP GENE; FAMILY HISTORY; GENE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; KRAS2 GENE; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; RECTUM CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; DNA, NEOPLASM; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECTAL NEOPLASMS; RISK FACTORS; SURVIVAL RATE;

EID: 79953322449     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25721     Document Type: Article

References (44)

1. Ulrich CM, Bigler J, Potter JD,. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 2006; 6: 130-40. (Pubitemid 43361545)
2. Medzhitov R,. Origin and physiological roles of inflammation. Nature 2008; 454: 428-35.
3. Il'yasova D, Colbert LH, Harris TB, Newman AB, Bauer DC, Satterfield S, Kritchevsky SB,. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev 2005; 14: 2413-8. (Pubitemid 41437845)
4. Eklund CM,. Proinflammatory cytokines in CRP baseline regulation. Adv Clin Chem 2009; 48: 111-36.
5. Hage FG, Szalai AJ,. The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk. Curr Atherosclerosis Rep 2009; 11: 124-30.
6. Schumacher W, Cockcroft J, Timpson NJ, McEniery CM, Gallacher J, Rumley A, Lowe G, Smith GD, Wilkinson IB, Ben-Shlomo Y,. Association between C-reactive protein genotype, circulating levels, and aortic pulse wave velocity. Hypertension 2009; 53: 150-7.
7. Bos SD, Suchiman HE, Kloppenburg M, Houwing-Duistermaat JJ, le Graverand MP, Seymour AB, Kroon HM, Slagboom PE, Meulenbelt I,. Allelic variation at the C-reactive protein gene associates to both hand osteoarthritis severity and serum high sensitive C-reactive protein levels in the GARP study. Ann Rheum Dis 2008; 67: 877-9. (Pubitemid 351829392)
8. Hage FG, Szalai AJ,. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am College Cardiology 2007; 50: 1115-22. (Pubitemid 47375011)
9. Crawford DC, Sanders CL, Qin X, Smith JD, Shephard C, Wong M, Witrak L, Rieder MJ, Nickerson DA,. Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 2006; 114: 2458-65. (Pubitemid 44901518)
10. Tsilidis KK, Helzlsouer KJ, Smith MW, Grinberg V, Hoffman-Bolton J, Clipp SL, Visvanathan K, Platz EA,. Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control 2009; 20: 1739-51.
11. Poole EM, Bigler J, Whitton J, Sibert JG, Potter JD, Ulrich CM,. C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps. Pharmacogenetics Genomics 2009; 19: 113-20.
12. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B,. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17: 4-12.
13. Rajala MW, Scherer PE,. Minireview: The Adipocyte-At the Crossroads of Energy Homeostasis, Inflammation, and Atherosclerosis. Endocrinology 2003; 144: 3765-73. (Pubitemid 37088727)
14. Slattery ML, Wolff RK, Curtin K, Fitzpatrick F, Herrick J, Potter JD, Caan BJ, Samowitz WS,. Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Mutat Res 2009; 660: 12-21.
15. Slattery ML, Wolff RK, Herrick J, Caan BJ, Samowitz W,. Tumor markers and rectal cancer: Support for an inflammation-related pathway. Int J Cancer 2009.
16. Zhang L, Kao WH, Berthier-Schaad Y, Plantinga L, Fink N, Smith MW, Coresh J,. C-Reactive protein haplotype predicts serum C-reactive protein levels but not cardiovascular disease risk in a dialysis cohort. Am J Kidney Dis 2007; 49: 118-26. (Pubitemid 44932197)
17. Slattery ML, Potter JD, Duncan DM, Berry TD,. Dietary fats and colon cancer: assessment of risk associated with specific fatty acids. Int J Cancer 1997; 73: 670-7. (Pubitemid 127483062)
18. Slattery ML, Caan BJ, Benson J, Murtaugh M,. Energy balance and rectal cancer: an evaluation of energy intake, energy expenditure, and body mass index. Nutr Cancer 2003; 46: 166-71. (Pubitemid 37504976)
19. Slattery ML, Potter J, Caan B, Edwards S, Coates A, Ma KN, Berry TD,. Energy balance and colon cancer-beyond physical activity. Cancer Res 1997; 57: 75-80. (Pubitemid 27020333)
20. Slattery ML, Edwards S, Curtin K, Ma K, Edwards R, Holubkov R, Schaffer D,. Physical activity and colorectal cancer. Am J Epidemiol 2003; 158: 214-24. (Pubitemid 36944414)
21. Edwards S, Slattery ML, Mori M, Berry TD, Caan BJ, Palmer P, Potter JD,. Objective system for interviewer performance evaluation for use in epidemiologic studies. Am J Epidemiol 1994; 140: 1020-8. (Pubitemid 24373007)
22. Samowitz WS, Curtin K, Ma KN, Edwards S, Schaffer D, Leppert MF, Slattery ML,. Prognostic significance of p53 mutations in colon cancer at the population level. Int J Cancer 2002; 99: 597-602. (Pubitemid 34461615)
23. Slattery ML, Curtin K, Anderson K, Ma KN, Ballard L, Edwards S, Schaffer D, Potter J, Leppert M, Samowitz WS,. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000; 92: 1831-6.
24. Samowitz WS, Curtin K, Schaffer D, Robertson M, Leppert M, Slattery ML,. Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study. Cancer Epidemiol Biomarkers Prev 2000; 9: 1193-7.
25. Slattery ML, Curtin K, Sweeney C, Levin TR, Potter J, Wolff RK, Albertsen H, Samowitz WS,. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer 2007; 120: 656-63. (Pubitemid 44969038)
26. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA,. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Human Genetics 2004; 74: 106-20. (Pubitemid 38085242)
27. Slattery ML, Curtin K, Wolff RK, Boucher KM, Sweeney C, Edwards S, Caan BJ, Samowitz W,. A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum 2009; 52: 1304-11.
28. Slattery ML, Wolff RK, Herrick J, Caan BJ, Samowitz W,. Tumor markers and rectal cancer: support for an inflammation-related pathway. Int J Cancer 2009; 125: 1698-704.
29. Burton P, Gurrin L, Sly P,. Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling. Stat Med 1998; 17: 1261-91. (Pubitemid 28274209)
30. Kuss O, McLerran D,. A note on the estimation of the multinomial logistic model with correlated responses in SAS. Comput Methods Programs Biomed 2007; 87: 262-9. (Pubitemid 47212598)
31. Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, Uitterlinden AG, Hofman A, Pols HA, Stricker BH,. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol 2006; 24: 5216-22. (Pubitemid 46631365)
32. Schetter AJ, Heegaard NH, Harris CC,. Inflammation and Cancer: Interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 2009; 31: 37-49.
33. Slattery ML, Wolff RK, Herrick JS, Caan BJ, Potter JD,. IL6 genotypes and colon and rectal cancer. Cancer Causes Control 2007; 18: 1095-105. (Pubitemid 47498159)
34. Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H,. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 53: 3-11.
35. Shen J, Arnett DK, Parnell LD, Peacock JM, Lai CQ, Hixson JE, Tsai MY, Province MA, Straka RJ, Ordovas JM,. Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study. Diabetes Care 2008; 31: 910-5.
36. Lee CC, You NC, Song Y, Hsu YH, Manson J, Nathan L, Tinker L, Liu S,. Relation of genetic variation in the gene coding for C-reactive protein with its plasma protein concentrations: findings from the Women's Health Initiative Observational Cohort. Clin Chem 2009; 55: 351-60.
37. Komurcu-Bayrak E, Erginel-Unaltuna N, Onat A, Ozsait B, Eklund C, Hurme M, Mononen N, Laaksonen R, Hergenc G, Lehtimaki T,. Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in Turkish adults. Atherosclerosis 2009; 206: 474-9.
38. Marioni RE, Deary IJ, Murray GD, Lowe GD, Rafnsson SB, Strachan MW, Luciano M, Houlihan LM, Gow AJ, Harris SE, Stewart MC, Rumley A, et al. Genetic variants associated with altered plasma levels of C-reactive protein are not associated with late-life cognitive ability in four Scottish samples. Behavior genetics 40: 54-57.
39. Ognjanovic S, Yamamoto J, Saltzman B, Franke A, Ognjanovic M, Yokochi L, Vogt T, Decker R, Le Marchand L,. Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population. Cancer Causes Control 2010; 21: 1131-8.
40. Miller DT, Zee RY, Suk Danik J, Kozlowski P, Chasman DI, Lazarus R, Cook NR, Ridker PM, Kwiatkowski DJ,. Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 2005; 69: 623-38. (Pubitemid 41556317)
41. Martinez-Calatrava MJ, Gonzalez-Sanchez JL, Martinez-Larrad MT, Perez-Barba M, Serrano-Rios M,. Common haplotypes of the C-reactive protein gene and circulating leptin levels influence the interindividual variability in serum C-reactive protein levels. The Segovia study. Thromb Haemost 2007; 98: 1088-95. (Pubitemid 350091139)
42. Eiriksdottir G, Smith AV, Aspelund T, Hafsteinsdottir SH, Olafsdottir E, Launer LJ, Harris TB, Gudnason V,. The interaction of adiposity with the CRP gene affects CRP levels: age, gene/environment susceptibilty-Reykjavik study. Int J obesity 2009; 33: 267-72.
43. Slattery ML, Levin TR, Ma K, Goldgar D, Holubkov R, Edwards S,. Family history and colorectal cancer: predictors of risk. Cancer Causes Control 2003; 14: 879-87. (Pubitemid 37500739)
44. Hindorff LA, Rice KM, Lange LA, Diehr P, Halder I, Walston J, Kwok P, Ziv E, Nievergelt C, Cummings SR, Newman AB, Tracy RP, et al. Common variants in the CRP gene in relation to longevity and cause-specific mortality in older adults: the Cardiovascular Health Study. Atherosclerosis 2008; 197: 922-30. (Pubitemid 351417896)